Cargando…

Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants

OBJECTIVE: Recent studies demonstrated cutaneous phosphorylated α synuclein (p‐syn) deposition in idiopathic and some monogenetic Parkinson disease (PD) patients, suggesting synucleinopathy identical to that in the brain. Although the LRRK2 Gly2385Arg (G2385R) variant is a common PD risk factor in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jing, Wang, Hao, Yuan, Yanpeng, Fan, Shiheng, Li, Lanjun, Jiang, Chenyang, Mao, Chengyuan, Shi, Changhe, Xu, Yuming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951097/ https://www.ncbi.nlm.nih.gov/pubmed/33527742 http://dx.doi.org/10.1002/acn3.51301

Ejemplares similares

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
por: Tezuka, Toshiki, et al.
Publicado: (2022)

Sex effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson's disease
por: Cui, Shi-Shuang, et al.
Publicado: (2021)

G2385R and I2020T Mutations Increase LRRK2 GTPase Activity
por: Ho, Dong Hwan, et al.
Publicado: (2016)

LRRK2 G2385R and R1628P Mutations Are Associated with an Increased Risk of Parkinson's Disease in the Malaysian Population
por: Gopalai, Aroma Agape, et al.
Publicado: (2014)

Effect of LRRK2 G2385R Variant on Subthalamic Deep Brain Stimulation Efficacy in Parkinson's Disease in a Han Chinese Population
por: Chen, Si, et al.
Publicado: (2019)

Connectivity of corticostriatal circuits in nonmanifesting LRRK2 G2385R and R1628P carriers
por: Zhang, Dongling, et al.
Publicado: (2022)

Curcumin Reduced H(2)O(2)- and G2385R-LRRK2-Induced Neurodegeneration
por: Zhang, Jinru, et al.
Publicado: (2021)

The Association between LRRK2 G2385R and Phenotype of Parkinson's Disease in Asian Population: A Meta-Analysis of Comparative Studies
por: Di, Wei, et al.
Publicado: (2018)

The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions
por: Carrion, Maria Dolores Perez, et al.
Publicado: (2017)

LRRK2 as a Potential Genetic Modifier of Synucleinopathies: Interlacing the Two Major Genetic Factors of Parkinson's Disease
por: Hyun, Cheol Hwan, et al.
Publicado: (2013)

Systemic Inflammation Index Values Are Associated With Worsened Disease Severity and Poor Response to Autoimmune Encephalitis Treatment
por: Mei, Yanliang, et al.
Publicado: (2021)

Optimization of the Detection Method for Phosphorylated α-Synuclein in Parkinson Disease by Skin Biopsy
por: Liu, Xiaojing, et al.
Publicado: (2020)

Rare variants in LRRK1 and Parkinson's disease
por: Schulte, Eva C., et al.
Publicado: (2013)

The Value of NOTCH2NLC Gene Detection and Skin Biopsy in the Diagnosis of Neuronal Intranuclear Inclusion Disease
por: Pang, Jie, et al.
Publicado: (2021)

A Novel LRRK2 Variant p.G2294R in the WD40 Domain Identified in Familial Parkinson’s Disease Affects LRRK2 Protein Levels
por: Ogata, Jun, et al.
Publicado: (2021)

Genetic Variants of LRRK2 in Taiwanese Parkinson’s Disease
por: Wu, Yih-Ru, et al.
Publicado: (2013)

High LRRK2 Levels Fail to Induce or Exacerbate Neuronal Alpha-Synucleinopathy in Mouse Brain
por: Herzig, Martin C., et al.
Publicado: (2012)

Transgenic LRRK2(R1441G) rats–a model for Parkinson disease?
por: Shaikh, Komal T., et al.
Publicado: (2015)

An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 Cohorts
por: Padmanabhan, Shalini, et al.
Publicado: (2020)

Increased PRR14 and VCAM-1 level in serum of patients with Parkinson's disease
por: Zheng, Huimin, et al.
Publicado: (2022)

LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’s
por: Wallings, Rebecca L., et al.
Publicado: (2020)

Genetic spectrum and clinical features of adult leukoencephalopathies in a Chinese cohort
por: Liu, Minglei, et al.
Publicado: (2023)

Glucocerebrosidase Involvement in Parkinson Disease and Other Synucleinopathies
por: Almeida, Maria do Rosário
Publicado: (2012)

Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor
por: Bright, Jessica M., et al.
Publicado: (2021)

Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
por: Gaig, Carles, et al.
Publicado: (2014)

Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
por: San Luciano, Marta, et al.
Publicado: (2017)

Expression Analysis of Lrrk1, Lrrk2 and Lrrk2 Splice Variants in Mice
por: Giesert, Florian, et al.
Publicado: (2013)

2385 Role of the antioxidant enzyme catalase in respiratory syncytial virus infection
por: Ansar, Maria, et al.
Publicado: (2018)

Biological Stoichiometry Regulates Toxin Production in Microcystis aeruginosa (UTEX 2385)
por: Wagner, Nicole D., et al.
Publicado: (2019)

Analysis of 12 GWAS-Linked Loci With Parkinson’s Disease in the Chinese Han Population
por: Fan, Liyuan, et al.
Publicado: (2021)

Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells
por: Hu, Xinchao, et al.
Publicado: (2020)

R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils
por: Fan, Ying, et al.
Publicado: (2021)

A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 Gene
por: Vinagre-Aragón, Ana, et al.
Publicado: (2021)

Linking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy
por: Colla, Emanuela
Publicado: (2019)

Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
por: Lai, Thuy Thi, et al.
Publicado: (2022)

Association of LRRK2 R1628P variant with Parkinson’s disease in Ethnic Han-Chinese and subgroup population
por: Zhang, Pei, et al.
Publicado: (2016)

G2019S Variation in LRRK2: An Ideal Model for the Study of Parkinson’s Disease?
por: Ren, Chao, et al.
Publicado: (2019)

Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies
por: Lamotte, Guillaume, et al.
Publicado: (2020)

Role of LRRK2 variant p.Gly2019Ser in patients with Parkinsonism
por: Sadhukhan, Dipanwita, et al.
Publicado: (2020)

Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_huf09921cuj45o6v4l5morkgbt